Introduction: Toxoplasmosis is a zoonosis that represents a serious public health problem, worldwide distributed. Pregnant women are part of the most risky group due to congenital sequels. The necessity of a preventive treatment for congenital infections is of great importance [1] Biotherapics, highly diluted medicines prepared with T. gondii according to the Brazilian Homeopathic Pharmacopoeia [2], is an important prevention strategy, ensuring a safe and cheap approach to protozoan infections [3]. However, little is known about the effects of different potencies and treatment schedules.
Aim: To evaluate the effect of biotherapic 200DH in mice infected with Toxoplasma gondii.
Material and methods: The study was approved by the Ethics Committee for Animal Experimentation of the Universidade Estadual de Maringá – Protocol n° 036/2009. Fourteen mice were used – swiss male aged 57 days divided into two groups according to the treatment (or its diluent biotherapic): BIOT-200DH and Control (cereal alcohol-7%). The biotherapic was prepared with homogenized mouse brain (20 cysts of T.gondii/100μL-average 242 bradyzoites / cyst), according to the Brazilian Homeopathic Pharmacopoeia in laminar flow. The experiment was performed as a blind randomized controlled trial. The animals were treated for 3 days immediately prior to infection. The treatment schedule was of 0.1mL/single dose/ day, by gavage. Animals aged 57 – 59 days were treated with biotherapic and were clinically evaluated. The animals were orally infected at the age of 60 days (20 cysts ME49-T. gondii). Within18-21 days of infection the clinical parameters were evaluated. On the 55th day of infection the eye fundus was Examined (Ophthalmoscope Welch Allyn ®) and the intraocular pressure was measured (Tonometer TONO-PEN ® XL). After 60 days of post-infection the animals were killed in a chamber saturated with halothane, the brains were homogenized and resuspended in 1 ml of saline solution. The cysts were counted according to a rate of 25 mL of suspension, covered with 24x24 mm glass, examined in its full length.
Results and discussion: The number of brain cysts was compared among groups using the Mann-Whitney test with 5% of significance. Although there was no significant difference among the groups (p =0.2943), the results are interesting: the number of cysts - average ± standard deviation –was of the 4.5 ± 3.3 in the BIOT-200DH group and of 9.7 ± 12.8 in the control group. It is necessary to emphasize the great variability within the control group expressed by the standard deviation.
Likewise, there was no significant difference among the average of intraocular pressure observed in the control group (8.9 ± 3.8) and the group BIOT-200DH (8.0 ± 2.6). Regarding fundoscopy, the control group presented 57.14% of the animals without changes and 42.86% with discreet subretinal hemorrhage. While in the BIOT-200DH group, 50% of the animals showed no change and 50% showed discreet subretinal hemorrhage. Compared with the results from the use of other biotherapic T. gondii potencies [4], these results indicate that mice infected with the protozoan reacted better to the potency 200DH, Although mortality. This better response may the chronic aspect of the infection and/ or the characteristics of host-parasite relationship in the infection with T. gondii that involves alterations in the central nervous system.
Conclusion: The highly diluted biotherapic 200DH T. gondii caused mortality in one animal in group however caused no significant difference other clinical and parasitological parameters evaluated although there was a decrease of parasitism brain of mice infected with the protozoan compared to control group.
Three-dimensional locations of ruptured retinal arterial macroaneurysms and their associations with the visual prognosis
